BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3035922)

  • 21. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report.
    Cavallo-Perin P; De Paoli M; Guiso G; Sapino A; Papotti M; Coda R; Pagano G
    Cancer; 1988 Dec; 62(12):2576-9. PubMed ID: 2847862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
    Devine BL; Carmichael HA; Russell RI; Joffe SN
    Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
    Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
    Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptozotocin treatment in pancreatic cholera (Verner-Morrison) syndrome.
    Pignal F; René E; Chayvialle JA; Rigaud D; Lehy T; Bonfils S
    Digestion; 1982; 24(3):176-82. PubMed ID: 6292031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VIPomas and the watery diarrhoea syndrome.
    Modlin IM; Bloom SR
    S Afr Med J; 1978 Jul; 54(2):53-6. PubMed ID: 705537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic diarrhea of infancy: nonbeta islet cell hyperplasia.
    Ghishan FK; Soper RT; Nassif ED; Younoszai MK
    Pediatrics; 1979 Jul; 64(1):46-9. PubMed ID: 221877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumors producer of hormones in the digestive system. Vasoactive intestinal polypeptide (VIP). Carcinoid].
    Anzures López ME
    Rev Gastroenterol Mex; 1986; 51(3):177-9. PubMed ID: 3026020
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
    Kane MG; O'Dorisio TM; Krejs GJ
    N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
    Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
    Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VIPoma syndrome.
    Mekhjian HS; O'Dorisio TM
    Semin Oncol; 1987 Sep; 14(3):282-91. PubMed ID: 2820063
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasma vasoactive intestinal polypeptide assay and the clinical significance].
    Yamaguchi K; Otsubo K; Haniuda C; Miyoshi S; Abe K; Ohnami S
    Nihon Rinsho; 1990 Feb; 48 Suppl():43-7. PubMed ID: 2162430
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature.
    Gilbard JP; Dartt DA; Rood RP; Rossi SR; Gray KL; Donowitz M
    Am J Med; 1988 Oct; 85(4):552-4. PubMed ID: 2845780
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of pancreatic and gastrointestinal hormone-secreting tumors].
    Yamaguchi K; Abe K
    Nihon Rinsho; 1983 Jun; 41(6):1231-7. PubMed ID: 6312125
    [No Abstract]   [Full Text] [Related]  

  • 36. WDHA syndrome caused by VIP-producing ganglioneuroblastoma.
    Kudo K; Kitajima S; Munakata H; Yagihashi S
    J Pediatr Surg; 1982 Aug; 17(4):426-8. PubMed ID: 6288909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
    Reubi JC; Heitz PU; Gyr K
    Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
    [No Abstract]   [Full Text] [Related]  

  • 38. Resolution of recurrent Verner-Morrison syndrome by resection of metastatic vipoma.
    Nagorney DM; Bloom SR; Polak JM; Blumgart LH
    Surgery; 1983 Feb; 93(2):348-53. PubMed ID: 6297109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal polypeptide-secreting ganglioneuromatosis affecting the entire colon and rectum.
    Rescorla FJ; Vane DW; Fitzgerald JF; West KW; Grosfeld JL
    J Pediatr Surg; 1988 Jul; 23(7):635-7. PubMed ID: 2849648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vasoactive intestinal polypeptide (VIP)--new radioimmunoassay and its possible clinical applications].
    Fried M; Beglinger C; Schulthess C; Gyr K
    Schweiz Med Wochenschr; 1986 Jul; 116(29):985-6. PubMed ID: 3020683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.